BSEM BioStem Technologies Inc (PK)

Caribbean International Holdings (Pink Sheets:CIHN) through its subsidiary, Regenerative BioScience, Inc., ("RBS") announced today that during the World Congress in Orlando, FL this past weekend, the Company's Advisory Board Member, Rafael Gonzalez, Ph.D., speech to the attendees at the World Congress was widely acclaimed and helped further enhance the Company's increasing image in the field of regenerative medicine.

Additionally, the Company management, Dr. Leonel Liriano, Dr. Rafael Gonzalez and a consulting firm met this past weekend in Orlando to discuss, among other matters, the addition of strategic personnel, facility additions and to plan major marketing incentives.

The Company agreed to engage the firm to plan and orchestrate a national/international marketing campaign in order to establish the Company's brand and increase the brand awareness. Part of the plan will include strategies to increase the Company's awareness to the public at large and to reach a number of strategic alliances with professionals in sports and medicine to further drive more prospective patients to the Company's facilities. The strategies will be designed to drastically increase not only the number of prospective applicants/patients who apply for the Company's services, but to hopefully increase the conversion rate of those who do apply, by potentially providing the prospective applicants with financial assistance alternatives.

Chairman and CEO of Caribbean International Holdings, stated, "Raphael's presentation at the World Congress was very well received. His association with the Company has added to the Company's profile in this burgeoning industry."

About The Company:

Caribbean International Holdings, Inc. is a holding company for Regenerative BioScience, Inc. ("RBS"). For more information about the Company or Dr. Leonel Liriano or Rafael Gonzalez, Ph.D. go to: http://www.regenerativebioscience.com/index.html

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available on at http://www.sec.gov.

CONTACT: Investor Contact:
         BioScience
         (941) 924-9400